Skip to content

Ozette vs Parse Biosciences

Ozette logo

Ozette

Unlocking the power of the immune system through computationally-driven analytics

29 employees · est. 2021 · Seattle, United States

VS
Parse Biosciences logo

Parse Biosciences

Scalable Single Cell Sequencing Without the Instrument

148 employees · est. 2018 · Seattle, United States

Parse Biosciences is the older company (2021 vs 2018); Parse Biosciences is the larger of the two.

Side-by-Side Comparison

Ozette Parse Biosciences
Founded
2021 2018 older
Headquarters
Seattle, United States Seattle, United States
Employees
29 148 larger
Industry
AI, Biotechnology, Life Sciences Biotechnology, Life Sciences, Clean Energy
Funding Stage
Series A Acquired
Total Funding
$32.00M $299.70M
Funding Rounds
2 6
Services
Adaptive Unmixing for Spectral Cytometry, AI-driven Computational Analysis, Data-driven Insights for Therapy Development, Collaborative Research and Clinical Development Single cell sequencing services, Whole transcriptome analysis, Data analytics for sequencing, Immune profiling (TCR and BCR), Automation of sequencing workflows
Target Customers
Pharmaceutical Companies, Academic Researchers, Clinical Development Organizations, Biotech Professionals Research laboratories, Biotech companies, Academic researchers, Biomedical scientists, Immunologists
Taxonomy
ImmunologySingle-Cell AnalysisCytometryComputational AnalyticsSpectral UnmixingImmune Monitoring +9 Single Cell SequencingCombinatorial CDNA BarcodingBiotechnology StartupCancer ResearchTissue RepairStem Cell Therapy +9
Website
ozette.com parsebiosciences.com
Ozette logo

About Ozette

Ozette, founded in 2021 and based in the United States, is pioneering advancements in the field of single-cell analysis with its proprietary, computationally-driven analytics platform. Specifically designed for cytometry data, Ozette's platform automates complex analytical workflows, from raw FCS fi...

Parse Biosciences logo

About Parse Biosciences

Parse Biosciences, founded in 2018 and headquartered in the United States, is a dynamic player in the Biotechnology and Life Sciences sectors. With a compelling slogan—"Scalable Single Cell Sequencing Without the Instrument"—the company is focused on revolutionizing single cell sequencing. Its innov...

Also comparing in this category

Comparing more than these two?

Get Ozette, Parse Biosciences and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Ozette compare?

A PDF of Ozette and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Ozette was founded in 2021, based in Seattle, United States, with 29 employees. Ozette, founded in 2021 and based in the United States, is pioneering advancements in the field of single-cell analysis with its proprietary, computationally-driven analytics platform. Specifically de. Parse Biosciences was founded in 2018, based in Seattle, United States, with 148 employees. Parse Biosciences, founded in 2018 and headquartered in the United States, is a dynamic player in the Biotechnology and Life Sciences sectors. With a compelling slogan—"Scalable Single Cell Sequencing.
Ozette has raised $32.00M and Parse Biosciences $299.70M. Latest stage: Ozette Series A, Parse Biosciences Acquired.
Both work in Biotechnology and Life Sciences.

Compare Ozette with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ozette on 2 Apr 2026, and Parse Biosciences on 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout